Mylan Laboratories

Company has bought ophthalmology business of Taparia family-backed Famy Life Sciences

The Council of Scientific and Industrial Research (CSIR) and Mylan Laboratories Limited will collaborate to identify potential therapies for COVID-19, the country's premier research body said in a statement on Wednesday. A series of clinical trials will be conducted towards new and innovative solutions to manage the COVID-19 pandemic in India as part of this collaboration. The first of the clinical trials to be rolled out is a multiple-arm phase 3 study that will be conducted in adult patients with mild to moderate COVID-19 at risk of complications, it said. "The Council of Scientific & Industrial Research (CSIR), India's premier research organisation, and Mylan Laboratories Limited, the India-based subsidiary of leading global pharmaceutical company Mylan, today announced a partnership to address unmet patient needs amidst the evolving COVID-19 pandemic," according to the statement. "Under the partnership, CSIR's constituent laboratory Indian Institute of Chemical Technology ...

Company filed application for novel process for preparation of Sildenafil Citrate, the active ingredient of Pfizer's Viagra

Currently, he heads Mylan's Indian arm and OSD and API verticals; he has 25 years' experience in global generic pharma industry